Professional
Added to YB: 2025-03-12
Pitch date: 2025-03-10
SOFW.TA [bullish]
SofWave Medical Ltd.
+90.8%
current return
Author Info
No bio for this author
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally.
Market Cap
ILS 454.7M
Pitch Price
ILS 18.27
Price Target
N/A
Dividend
N/A
EV/EBITDA
96.56
P/E
646.00
EV/Sales
5.58
Sector
Health Care Equipment and Supplies
Category
growth
Arauca Capital Portfolio Holding: SofWave Medical Ltd.
SOFW.TA (holding update): Innovative skin rejuvenation tech with 20% topline growth vs competitors' decline. 40% recurring revenue at 100% margin. FDA-approved, non-invasive, painless. Global expansion, potential Nasdaq listing. Industry veteran management. EV $140M, 2027 est. $85M revenue, $12M EBIT. Kardashian endorsement. Risks: regulatory approvals, competition.
Read full article (6 min)